Clin2
NCT07591519Likely a fitRecruiting

Safety study of IBI3035 in healthy men

Healthy Person

Treatments studied

This is an early-stage safety study of a new drug called IBI3035 in healthy adult volunteers. Researchers want to understand how the drug is absorbed and processed by the body, and whether it causes any side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
144 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You must be a healthy male aged 18–45 years and a Chinese citizen
  • Your weight and height must fall within a normal, healthy range (BMI 19.0–24.0)
  • Your blood sugar levels must be normal, with no history of diabetes or blood sugar problems in the past 3 months
  • You cannot have serious medical conditions affecting your heart, lungs, stomach, kidneys, immune system, or nervous system
  • You must agree to use reliable contraception for 6 months after the study and not donate sperm during this time
  • You cannot have taken certain medications (like steroids or blood pressure drugs) in the past 4 weeks

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07120425Recruiting· Phase 1
Testing IBI3032 in healthy volunteers

This study tests a new drug called IBI3032 in healthy volunteers to see how safe it is and how the body processes it. If you are in good health, you may be able to join.

Lenexa, Kansas
NCT07160400Recruiting· Phase 1
Study of IBI3032 for healthy participants and those with overweight or obesity

This trial tests a new medication called IBI3032 in healthy people and those with overweight or obesity. It aims to see if the drug is safe and how the body processes it.

Shanghai, Shanghai Municipality
NCT07630233Not yet recruiting· Phase 1
Safety and effects of UBT38006 injection in healthy men

This early-stage study tests a new injectable medication (UBT38006) in healthy adult men to understand how safe it is and how the body processes it. Researchers want to make sure the injection doesn't cause serious side effects and works as expected.

Hefei, Anhui
NCT07765160Not yet recruiting· Phase 1
Study of IBI3040 for weight loss in overweight and obese adults

This study tests an investigational drug called IBI3040 in healthy volunteers and in people who are overweight or obese. It aims to see if the drug is safe and how it affects body weight.

Shanghai, Shanghai Municipality
NCT07225517Recruiting· Phase 1
Safety study of BIIB145 in healthy adults

This study tests a new drug called BIIB145 in healthy volunteers to see if it's safe and how the body handles it. It helps researchers learn about the drug before testing it in people with specific conditions.

Austin, Texas
NCT07708493Not yet recruiting· Phase 1
Study of a new medicine in healthy men with normal or overweight

This study tests how a new medicine (BI 3034701) moves through the body in healthy men who have normal weight or are overweight. It helps find the right dose and understand how the medicine works.

Hear when a new Healthy Person trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.